Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 329-332, June 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lamirande, G.
Right arrow Articles by Cantero, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lamirande, G.
Right arrow Articles by Cantero, A.

Ribonucleic Acid Composition of Rat Liver Tumor Induced by 4-Dimethylaminoazobenzene*

Gaston de Lamirande{dagger}, Claude Allard and Antonio Cantero

( Research Laboratories, Montreal Cancer Institute, Notre-Dame Hospital, Montreal, Canada)

The nucleotide composition of the ribonucleic acid of the homogenate and of isolated cellular fractions of primary liver tumor was determined. It was found that the RNA compositions of all cellular fractions resemble one another. Therefore, the ribonucleic acid composition is not specific for each cellular fraction, as was observed in normal liver. The relative homogeneity of RNA in the cellular fraction of tumor is characterized by a high guanylic acid content. These findings are discussed in relation to the possible role of ribonucleic acids in protein synthesis.

* This investigation was supported by a grant-in-aid from the National Cancer Institute of Canada and from the Damon Runyan Memorial Fund for Cancer Research, Inc.

{dagger} Fellow of the Damon Runyon Memorial Fund for Cancer Research, Inc.

Received 2/24/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.